glucose-galactose malabsorption
glucose-galactose malabsorption
Explore linked clinical trials. Standard reference: MONDO:00117312 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Myotonic Dystrophy - Vascular and Cognition | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Insulin Resistance, Muscular Disorders, Atrophic, Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, glucose-galactose malabsorption, hereditary disease, hyperinsulinism, inherited neurodegenerative disorder, metabolic disease, muscle tissue disorder, muscular dystrophy, musculoskeletal system disorder, myotonic dystrophy, myotonic syndrome, nervous system disorder, neurodegenerative disease, neuromuscular disease, tauopathy | Active, not recruiting | Not stated | 2026-05-22 | NCT04656210 | |
| Maple Syrup Carbohydrate Dose-Response on 20-km Cycling Time-Trial Performance | glucose-galactose malabsorption | Not yet recruiting | Not applicable | 2026-02-05 | NCT07389837 |